Navigation Links
Pomegranate juice may cut atherosclerosis risk in diabetics

An Israeli study has revealed that the risk of atherosclerosis in diabetics may be decreased by drinking pomegranate juice. This condition is characterized by// thickening and hardening of artery walls. 80% of the diabetics who die are affected by atherosclerosis.

This study, conducted by researchers at the Technion-Israel Institute of Technology revealed that there was a decrease in the risk of developing atherosclerosis in people who drank 180 ml (6 oz.) of pomegranate juice daily for a period of 90 days.

The uptake of oxidized LDL or “bad” cholesterol by immune cells called macrophages helps in the development of atherosclerosis. Pomegranate juice seems to prevent this uptake.

According to the lead researcher Professor Michael Aviram of the Technion Faculty of Medicine, though the sugars present in pomegranate juice were similar to those found in other fruit juices, these sugars did not aggravate diabetes.

"In most juices, sugars are present in free – and harmful – forms,” said Aviram. “In pomegranate juice, however, the sugars are attached to unique antioxidants, which actually make these sugars protective against atherosclerosis.”

Though this study was conducted on a small-scale, with only 20 participants, it is a part of a bigger proposal investigating the effects of pomegranates on cholesterol oxidation and cardiovascular diseases.

The antioxidant and anti-atherosclerotic benefits of licorice, olive oil, onions and pomegranates have already been worked upon by Aviram and also has published his findings. He was the first to prove inhibition of cholesterol oxidation and arteriosclerosis by consumption of red wine.

Decrease in risk of Alzheimer's disease, prostate cancer and heart disease by consuming pomegranate juice has already been proved in previous studies.

The current study is published in the August 2006 issue of Atherosclerosis.

<
'"/>




Page: 1

Related medicine news :

1. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
2. Pomegranate juice to check fetal brain injury
3. Pomegranate juice delays prostate cancer
4. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
5. Pomegranates Found To Slow Prostate Cancer Progression
6. Pomegranate Juice Consumption May Improve Myocardial Ischemia
7. Pomegranates In Snack-Sized Bars
8. Pomegranate Juice Remedy for Prostate Cancer
9. Pomegranate juice could kill cancer cells
10. Science Builds Behind Pomegranate Extracts for Health
11. Drink grape juice for health
Post Your Comments:
(Date:12/2/2008)...Newswire/ -- diaDexus, Inc. today,announced that ...mat of the,PLAC Test for Lp-PLA2. This automated ... a wide range of clinical chemistry analyzers, was...tration (FDA) in December 2007. diaDexus also,ann...st to Europe. , The PLAC Test is the only b...
(Date:12/2/2008)...t a symposium today hosted by Johns,Hopkins Univ...archers presented,the latest research in brain pl...cience into technology to improve lives. Henry Mah...vidence that cognitive intervention developed by,...brain,s ability to,reorganize itself throughout l...
(Date:12/2/2008)...ewswire/ -- Are you unhappy with your smile but ar...ailable? , , The Pennsylvania Dental Associ...ptions exist to improve your smile. Your dentist c... determine a suitable option to help restore your ...tal options. , , , , Tooth whi...
(Date:12/2/2008)...ed for 3.5 percent of high school athletes, injuri... to examine rare injuries and conditions of U.S. h...uries, dental injuries, neck and cervical injuries...t in high morbidity, costly surgeries and treatmen... associated with the highest rate of rare injuries...
Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...riggered by viral cold are common in preschoolers....since the frequency disappears by school age. //Th...r oral steroids at the first sign of an attack. Bu...ive is controversial. The research shows a course...
...be a major improvement for HIV patients in less-de...sess a patient's response to HIV medication.// HIV... This treatment is now becoming available in Afric...etermine the CD4 cell count are needed. A low CD4 ...
...to help acne patients. A new study highlights the ...is is important because this skin disease can lead...b and sometimes even suicide. Doctors from London ...ate facial acne. Thirty-one of the patients receiv...
...is year’s meeting of the American Society of Thera...ment //of external beam radiation may be what it t...ers that have spread to the bone. More than 160 ho... States and Canada were involved in a study of abo...
Other Medicine News:
(Date:12/1/2008)...st policy , , ROCHESTER, Minn., Dec. 1 /PR...ic finds the use of the drug therapy etanercept in...e inflammation of the liver caused by excessive co... published in the December issue of Gastroenterol... VIDEO ALERT: Additional audio and video resource...
(Date:12/1/2008)...rstCall/ -- Vical Incorporated (Nasdaq: VICL ) a...tone payment from Merck & Co., Inc. based on M...ial of an investigational plasmid DNA (pDNA) cance...,s DNA gene delivery technology and encodes human ... the subject of separate license agreement. , ...
(Date:11/27/2008)...acute lymphoblastic leukemia relapse cases arise f...s , , MEMPHIS, Tenn., Nov. 27 /PRNewswire-U...search Hospital have identified distinctive geneti...te lymphoblastic leukemia (ALL) that cause relapse...ents for ALL relapse in children and, ultimately, ...
(Date:11/25/2008)...wire-USNewswire/ -- Kleinert Kutz and University ....S. hand transplant on Messina, New York resident,...tal Hand Care Center on Monday, November 24. The ...pleted shortly after 9 p.m. in a record nine hours...bin/prnh/20081125/DC48555-a ) , (Photo: http:...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 1Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 2Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday May 14 2008 5202 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 2FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1
...007 – Intercell AG (VSE,“ICLL”)...& Co., Inc. on the results of a Phase I study ...rs comparing safety and,immunogenicity of differen...he Staphylococcus aureus vaccine is based on a con...uo;s Antigen Identification,Program (AIP®) and...
...2007 /PRNewswire-FirstCall/ -- A total,of 20 oral ...Schering-Plough,s hepatitis products, including PE... (ribavirin, USP) combination,therapy for chronic ...previr (SCH 503034), the company,s investigational... clinical development, will,be presented by leadin...
Other Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
... integrated technology and service--mobile,outpati...heartbeat, ECG monitoring, analysis and response, ...y focused on helping physicians diagnose and treat...in diagnosing and treating arrhythmia. Delays can ...
...rmance temperature controlled shaker which accommo...eed and incubation time are fully programmable via...ed on the LCD in real time. Microprocessor-control... provide uniform incubation with less than 0.6 C v...
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: